By bertrand
🚀 Cardiawave at EuroPCR 2026 May, 12 2026 Two scientific presentations will highlight our non-invasive ultrasound therapy Valvosoft®, contributing to ongoing discussions on the management of aortic stenosis. Programme highlights:🫀 Non-invasive ultrasound therapy using Valvosoft®: a new way to treat moderate aortic stenosis, presented by A. Latib (Montefiore Medical Center, New York)📅 May 19, 2026 | … Continued
By bertrand
🚀 2 patients successfully treated at HEGP ! April 23, 2026 🚀 2 patients were successfully treated last week at Hôpital Européen Georges-Pompidou (HEGP) with Valvosoft®, following its CE marking ✅ 🏥 This achievement represents an important step as Valvosoft® enters routine clinical use in Europe and highlights the close collaboration between innovative medtech teams and … Continued
By bertrand
Journée du Souffle au Coeur 2026 April 16 2026 We are pleased to share the post from Alliance du Cœur ❤️, who—together with the Cardiology Department of CHU Rouen—is organizing a public awareness day on April 16 with free, walk‑in consultations to help detect heart valve diseases early: https://www.linkedin.com/feed/update/urn:li:activity:7445394628255817729/?originTrackingId=GrouB5xc%2Fr6TT2kTs1QVwg%3D%3D This initiative strongly resonates with our mission … Continued
By bertrand
🌟 From Solidarity to Celebration: A Team Seminar to Remember! April 4, 2026 🌟 From Solidarity to Celebration: A Team Seminar to Remember! 🌟 2 weeks ago, our team came together for our annual team seminar—an afternoon that blended purpose, creativity, and joy. We didn’t just celebrate our recent CE Marking achievement; we also took meaningful action. 💡 Learning … Continued
By bertrand
🎙️Cardiawave featured in L’Écho Santé by Medicen Paris Region March 19, 2026 🎙️We are proud to be featured in the latest episode of L’Écho Santé by Medicen Paris Region, highlighting the crucial role of public–private partnerships in advancing health innovation. At 34:56, François Ballet — President of the Project Evaluation Committee at Medicen Paris Region — … Continued
By bertrand
🎙️Our CEO Carine Schorochoff featured in the new episode of The Crux of Cardio March 10, 2026 🎙️We are pleased to see our CEO, @Carine Schorochoff, featured in the new episode of The Crux of Cardio, hosted by Jordan Burgin. Thank you for the insightful conversation highlighting the importance of innovating in calcified aortic stenosis with … Continued
By bertrand
🚀 Cardiawave at MedInTechs 2026 March, 5 2026 Cardiawave was present at the Innovation Village, hosted on Medicen’s booth 🤝 We discussed our non‑invasive ultrasound therapy (NIUT) for the treatment of severe aortic stenosis 💗🔊 — a breakthrough technology that recently received its CE marking ✅ A major milestone for patients and for the MedTech community. A warm … Continued
By bertrand
🔎Important perspectives on access to cardiovascular innovation in France March 3, 2026 A recent Le Monde op-ed signed by leading experts in interventional cardiology highlights delays in accessing cutting-edge medical devices in France — delays that may represent a real loss of opportunity for patients. At Cardiawave, we believe that patients should benefit rapidly and safely … Continued
By bertrand
🚀Cardiawave featured in BiotechFinances February 26, 2026 🚀 Cardiawave continues to push innovation while keeping clinical development efficient and impactful! We are proud to be featured in Biotech Finances following a major milestone: the CE marking for our non‑invasive ultrasound-based treatment for severe aortic stenosis. Our CEO, Carine Schorochoff, highlights our approach:👉 a highly skilled and agile … Continued
By bertrand
📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors! February 2, 2026 We are delighted to announce that Hardip Thakerar has joined Cardiawave’s Board of Directors. Hardip brings over a decade of experience in structural heart therapies and transcatheter valve innovations. She currently works at InQB8 Medical Technolgies, a medtech incubator, and has previously held … Continued